People · Operator
Named in public records as an officer, director or promoter · active 2018–2018 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Omniome, Inc. | — | Biotechnology | Series C | $100.2M | $2.5B | 2018 |
John S. Murphy, Ph.D. at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside John S. Murphy, Ph.D. on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| CATHERINE S. LEE | 1 | 2 |
| Kandaswamy Vijayan | 1 | 2 |
| Kim S. Kamdar, Ph.D. | 1 | 1 |
| David S. Mullarkey | 1 | 1 |
| Ken S. Song, M.D., Ph.D. | 1 | 1 |
| Kelly S. Perez | 1 | 1 |
| Arnold S. Oliphant | 1 | 1 |
| David S. Cruikshank | 1 | 1 |
| Michael S. Yi | 1 | 1 |
| Millard Y Chan | 1 | 1 |
| Boris S. Nikolic, M.D. | 1 | 1 |
| Dan S. Zabrowski | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.